_version_ 1783537194533650432
author Wambier, Carlos Gustavo
Vaño-Galván, Sergio
McCoy, John
Gomez-Zubiaur, Alba
Herrera, Sabina
Hermosa-Gelbard, Ángela
Moreno-Arrones, Oscar M.
Jiménez-Gómez, Natalia
González-Cantero, Alvaro
Fonda-Pascual, Pablo
Segurado-Miravalles, Gonzalo
Shapiro, Jerry
Pérez-García, Bibiana
Goren, Andy
author_facet Wambier, Carlos Gustavo
Vaño-Galván, Sergio
McCoy, John
Gomez-Zubiaur, Alba
Herrera, Sabina
Hermosa-Gelbard, Ángela
Moreno-Arrones, Oscar M.
Jiménez-Gómez, Natalia
González-Cantero, Alvaro
Fonda-Pascual, Pablo
Segurado-Miravalles, Gonzalo
Shapiro, Jerry
Pérez-García, Bibiana
Goren, Andy
author_sort Wambier, Carlos Gustavo
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-7242206
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-72422062020-05-22 Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign” Wambier, Carlos Gustavo Vaño-Galván, Sergio McCoy, John Gomez-Zubiaur, Alba Herrera, Sabina Hermosa-Gelbard, Ángela Moreno-Arrones, Oscar M. Jiménez-Gómez, Natalia González-Cantero, Alvaro Fonda-Pascual, Pablo Segurado-Miravalles, Gonzalo Shapiro, Jerry Pérez-García, Bibiana Goren, Andy J Am Acad Dermatol Research Letter [Figure: see text] by the American Academy of Dermatology, Inc. 2020-08 2020-05-22 /pmc/articles/PMC7242206/ /pubmed/32446821 http://dx.doi.org/10.1016/j.jaad.2020.05.079 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Wambier, Carlos Gustavo
Vaño-Galván, Sergio
McCoy, John
Gomez-Zubiaur, Alba
Herrera, Sabina
Hermosa-Gelbard, Ángela
Moreno-Arrones, Oscar M.
Jiménez-Gómez, Natalia
González-Cantero, Alvaro
Fonda-Pascual, Pablo
Segurado-Miravalles, Gonzalo
Shapiro, Jerry
Pérez-García, Bibiana
Goren, Andy
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
title Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
title_full Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
title_fullStr Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
title_full_unstemmed Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
title_short Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
title_sort androgenetic alopecia present in the majority of patients hospitalized with covid-19: the “gabrin sign”
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242206/
https://www.ncbi.nlm.nih.gov/pubmed/32446821
http://dx.doi.org/10.1016/j.jaad.2020.05.079
work_keys_str_mv AT wambiercarlosgustavo androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT vanogalvansergio androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT mccoyjohn androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT gomezzubiauralba androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT herrerasabina androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT hermosagelbardangela androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT morenoarronesoscarm androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT jimenezgomeznatalia androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT gonzalezcanteroalvaro androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT fondapascualpablo androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT seguradomiravallesgonzalo androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT shapirojerry androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT perezgarciabibiana androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign
AT gorenandy androgeneticalopeciapresentinthemajorityofpatientshospitalizedwithcovid19thegabrinsign